Boundless Bio Statistics

Total Valuation

Boundless Bio has a market cap or net worth of $33.45 million. The enterprise value is -$133.45 million.

Market Cap	33.45M
Enterprise Value	-133.45M

Important Dates

The last earnings date was Thursday, March 27, 2025, before market open.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Boundless Bio has 22.30 million shares outstanding. The number of shares has increased by 1,296.65% in one year.

Current Share Class	22.30M
Shares Outstanding	22.30M
Shares Change (YoY)	+1,296.65%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	1.75%
Owned by Institutions (%)	49.64%
Float	14.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.20
P/TBV Ratio	0.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -45.77% and return on invested capital (ROIC) is -31.81%.

Return on Equity (ROE)	-45.77%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-31.81%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$907,819
Employee Count	72
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	2.00
200-Day Moving Average	3.08
Relative Strength Index (RSI)	34.10
Average Volume (20 Days)	88,189

Short Selling Information

The latest short interest is 415,465, so 1.86% of the outstanding shares have been sold short.

Short Interest	415,465
Short Previous Month	330,942
Short % of Shares Out	1.86%
Short % of Float	2.93%
Short Ratio (days to cover)	6.49

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-73.27M
Pretax Income	n/a
Net Income	-65.36M
EBITDA	-72.21M
EBIT	-73.27M
Earnings Per Share (EPS)	-$3.85

Full Income Statement

Balance Sheet

The company has $167.14 million in cash and $121,000 in debt, giving a net cash position of $167.01 million or $7.49 per share.

Cash & Cash Equivalents	167.14M
Total Debt	121,000
Net Cash	167.01M
Net Cash Per Share	$7.49
Equity (Book Value)	165.08M
Book Value Per Share	7.42
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Boundless Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,296.65%
Shareholder Yield	-1,296.65%
Earnings Yield	-194.77%
FCF Yield	n/a

Analyst Forecast

The average price target for Boundless Bio is $22.50, which is 1,400.00% higher than the current price. The consensus rating is "Buy".

Price Target	$22.50
Price Target Difference	1,400.00%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a